BMS-986504 demonstrates durable responses in MTAP-deleted NSCLC, including EGFR and ALK-positive tumors

Updated on: October 02,2025

BMS-986504 demonstrates durable responses in MTAP-deleted NSCLC, including EGFR and ALK-positive tumors

Updated on:October 02,2025

EU health agency urges stepped-up antibiotic resistance fight

Methicillin-resistantStaphylococcus aureus. Credit: NIH/NIAIDThe European Union health agency on Monday warned that Europe was set to miss goals on reducing the use of antibiotics, calling for a

Updated on: December 05,2024

EU health agency urges stepped-up antibiotic resistance fight

Methicillin-resistantStaphylococcus aureus. Credit: NIH/NIAIDThe European Union health agency on Monday warned that Europe was set to miss goals on reducing the use of antibiotics, calling for a

Updated on:December 05,2024

Weekly Update of Drug News-13/2/2025

Updated on: February 14,2025

Weekly Update of Drug News-13/2/2025

Updated on:February 14,2025

Blocker drugs may defeat a problematic protein in synovial sarcoma's genes

Updated on: October 05,2025

Blocker drugs may defeat a problematic protein in synovial sarcoma's genes

Updated on:October 05,2025

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer

Updated on: October 04,2025

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer

Updated on:October 04,2025

Weekly Update of Drug News-20/2/2025

Updated on: February 24,2025

Weekly Update of Drug News-20/2/2025

Updated on:February 24,2025

Simultaneous cell isolation technology shows clinical feasibility for increased accuracy in cancer diagnostics

Updated on: October 03,2025

Simultaneous cell isolation technology shows clinical feasibility for increased accuracy in cancer diagnostics

Updated on:October 03,2025

Gene-edited immune cells show promise for universal 'off-the-shelf' cancer therapy

Updated on: October 05,2025

Gene-edited immune cells show promise for universal 'off-the-shelf' cancer therapy

Updated on:October 05,2025

Weekly Update of Drug News-2/12/2025

1.European Commission approves Roche’s Lunsumio subcutaneous for relapsed or refractory follicular lymphomaOn November 19, 2025, Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the European Commission has granted conditional marketing authorization for

Updated on: December 02,2025

Weekly Update of Drug News-2/12/2025

1.European Commission approves Roche’s Lunsumio subcutaneous for relapsed or refractory follicular lymphomaOn November 19, 2025, Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the European Commission has granted conditional marketing authorization for

Updated on:December 02,2025

Study finds gaps in support service use among older breast cancer patients

Updated on: October 06,2025

Study finds gaps in support service use among older breast cancer patients

Updated on:October 06,2025